CIK 0001395937 · Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320162505
- Phone
- 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- 4 Planned sale Director sold 52,855 shares at $20.40 ($1,078,068)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Financial Officer sold 577 shares at $22.31 ($12,873)
- 4 Planned sale Director sold 52,855 shares at $21.18 ($1,119,421)
- 144 Insider Sale of Securities
- 8-K Event Agreement ended · Other events
- 424B5 Offering Prospectus
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results
- 4 Planned sale Director sold 52,855 shares at $21.41 ($1,131,478)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- DEFA14A Proxy Proxy Materials
- 4 Planned sale Director sold 52,855 shares at $19.53 ($1,032,237)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change · Regulation FD disclosure
Page 10 of 33 · 660 filings